Victory Capital Management’s T2 Biosystems, Inc TTOO Stock Holding History

Victory Capital Management’s Portfolio TTOO Stock Details TTOO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-311	Closed	-$6.88K	–	2670
2023 Q3	$6.88K	Buy	+311	New	+$8.11K	﹤0.01%	2494
2022 Q3	–	Sell	-5	Closed	-$4K	–	2798
2022 Q2	$4K	Hold	5	–	–	﹤0.01%	2685
2022 Q1	$8K	Hold	5	–	–	﹤0.01%	2690
2021 Q4	$12K	Hold	5	–	–	﹤0.01%	2728
2021 Q3	$22K	Hold	5	–	–	﹤0.01%	2726
2021 Q2	$27K	Hold	5	–	–	﹤0.01%	2689
2021 Q1	$37K	Hold	5	–	–	﹤0.01%	2687
2020 Q4	$30K	Hold	5	–	–	﹤0.01%	2485
2020 Q3	$31K	Buy	5 +1	+25%	+$7.41K	﹤0.01%	2407
2020 Q2	$24K	Sell	4 -2	-33%	-$8.49K	﹤0.01%	2442
2020 Q1	$20K	Buy	+6	New	+$24.9K	﹤0.01%	3107
2019 Q4	–	Sell	-1	Closed	-$14K	–	3407
2019 Q3	$14K	Buy	+1	New	+$8.03K	﹤0.01%	3162

Other funds holding TTOO

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

GCP

GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Victory Capital Management's TTOO Position: Q4 2023 in Review

Victory Capital Management sold out of T2 Biosystems, Inc (TTOO) in Q4 2023, closing a stake of 311 shares — an estimated $6.88K sold.

Victory Capital Management first reported a position in TTOO in Q3 2019 and held it in 12 quarters. The position peaked at $37K in Q1 2021. 21 funds tracked by Wall St. Rank hold TTOO as of Q4 2023.

Victory Capital Management reported no remaining T2 Biosystems, Inc position as of Q4 2023 after selling out during the quarter.
Victory Capital Management sold 311 T2 Biosystems, Inc shares in Q4 2023, an estimated $6.88K.
Victory Capital Management first reported a position in T2 Biosystems, Inc in Q3 2019 and held it in 12 quarters.
Victory Capital Management's T2 Biosystems, Inc position peaked at $37K in Q1 2021.
21 funds tracked by Wall St. Rank held T2 Biosystems, Inc as of Q4 2023.

Based on Victory Capital Management's 13F filing for Q4 2023, filed 5 Feb 2024.